EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatic ribosomal protein S6 (Rps6) insufficiency results in failed bile duct development and loss of hepatocyte viability; a ribosomopathy-like phenotype that is partially p53-dependent

Sarah A Comerford, Elizabeth A Hinnant, Yidong Chen, Robert E Hammer

PLOS Genetics · 2023

DOI: 10.1371/journal.pgen.1010595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, 2023. Verfasst von Sarah A Comerford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, University of Texas Southwestern Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defective ribosome biogenesis (RiBi) underlies a group of clinically diverse human diseases collectively known as the ribosomopathies, core manifestations of which include cytopenias and developmental abnormalities that are believed to stem primarily from an inability to synthesize adequate numbers of ribosomes and concomitant activation of p53. The importance of a correctly functioning RiBi machinery for maintaining tissue homeostasis is illustrated by the observation that, despite having a paucity of certain cell types in early life, ribosomopathy patients have an increased risk for developing cancer later in life. This suggests that hypoproliferative states trigger adaptive responses that can, over time, become maladaptive and inadvertently drive unchecked hyperproliferation and predispose to cancer. Here we describe an experimentally induced ribosomopathy in the mouse and show that a normal level of hepatic ribosomal protein S6 (Rps6) is required for proper bile duct development and preservation of hepatocyte viability and that its insufficiency later promotes overgrowth and predisposes to liver cancer which is accelerated in the absence of the tumor-suppressor PTEN. We also show that the overexpression of c-Myc in the liver ameliorates, while expression of a mutant hyperstable form of p53 partially recapitulates specific aspects of the hepatopathies induced by Rps6 deletion. Surprisingly, co-deletion of p53 in the Rps6-deficient background fails to restore biliary development or significantly improve hepatic function. This study not only reveals a previously unappreciated dependence of the developing liver on adequate levels of Rps6 and exquisitely controlled p53 signaling, but suggests that the increased cancer risk in ribosomopathy patients may, in part, stem from an inability to preserve normal tissue homeostasis in the face of chronic injury and regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53NeoplasmsHumansAnimalsMiceRibosomal Protein S6HepatocytesPhenotypeBile DuctsRibosomal Proteins

Substanzen

Ribosomal Protein S6Tumor Suppressor Protein p53Ribosomal Proteins

Autor:innen und Institutionen

  • Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
  • Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
  • Department of Population Health Sciences, University of Texas Health San Antonio, San Antonio, Texas, United States of America.
  • Greehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, Texas. United States of America.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • University of Texas Southwestern Medical Center
  • Cancer Prevention and Research Institute of Texas
  • National Cancer Institute

Zitieren

APA

Comerford, S. A., Hinnant, E. A., Chen, Y., & Hammer, R. E. (2023). Hepatic ribosomal protein S6 (Rps6) insufficiency results in failed bile duct development and loss of hepatocyte viability; a ribosomopathy-like phenotype that is partially p53-dependent. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1010595

Vancouver

Comerford SA, Hinnant EA, Chen Y, Hammer RE. Hepatic ribosomal protein S6 (Rps6) insufficiency results in failed bile duct development and loss of hepatocyte viability; a ribosomopathy-like phenotype that is partially p53-dependent. PLOS Genetics. 2023. doi:10.1371/journal.pgen.1010595

BibTeX
@article{Comerford2023,
  author = {Comerford, Sarah A and Hinnant, Elizabeth A and Chen, Yidong and Hammer, Robert E},
  title = {Hepatic ribosomal protein S6 (Rps6) insufficiency results in failed bile duct development and loss of hepatocyte viability; a ribosomopathy-like phenotype that is partially p53-dependent},
  journal = {PLOS Genetics},
  year = {2023},
  doi = {10.1371/journal.pgen.1010595}
}
Kostenlos starten →